Suchergebnisse - "31YO63LBSN"

PubPharm (715)

1

Reducing affinity as a strategy to boost immunomodulatory antibody agonism

enthalten in: Nature | 2023

von Yu, X. | Orr, C. | Chan, H. | +10

CommentIn: Nature. 2023 Feb;614(7948):416-418. - PMID 36725942

2

Prognostic role of modified Glasgow Prognostic score in elderly non-small cell lung cancer patients treated with anti-PD-1 antibodies

enthalten in: Respiratory investigation | 2023

von Tanaka, T. | Yoshida, T. | Masuda, K. | +8

3

The combination of soluble forms of PD-1 and PD-L1 as a predictive marker of PD-1 blockade in patients with advanced cancers : a multicenter retrospective study

enthalten in: Frontiers in immunology | 2023

von Kurosaki, T. | Chamoto, K. | Suzuki, S. | +17

4

Real-world data prognostic model of overall survival in patients with advanced NSCLC receiving anti-PD-1/PD-L1 immune checkpoint inhibitors as second-line monotherapy

enthalten in: Cancer reports (Hoboken, N.J.) | 2022

von Julian, C. | Machado, R. | Girish, S. | +9

5

Enhanced stimulation of antigen-specific immune responses against nucleophosmin 1 mutated acute myeloid leukaemia by an anti-programmed death 1 antibody

enthalten in: British journal of haematology | 2022

von Greiner, J. | Goetz, M. | Schuler, P. | +6

6

Severe Immune-Related Adverse Events in Patients Treated with Nivolumab for Metastatic Renal Cell Carcinoma Are Associated with PDCD1 Polymorphism

enthalten in: Genes | 2022

von Kobayashi, M. | Numakura, K. | Hatakeyama, S. | +11

7

PD-1 targeted immunotherapy for advanced hepatocellular carcinoma : current utilization and outcomes in the USA

enthalten in: Future oncology (London, England) | 2022

von Uhlig, J. | Stein, S. | Kim, H.

8

Massive digital gene expression analysis reveals different predictive profiles for immune checkpoint inhibitor therapy between adenocarcinoma and squamous cell carcinoma of advanced lung cancer

enthalten in: BMC cancer | 2022

von Kaneda, T. | Kurata, T. | Yoshida, T. | +6

9

A PD-1/PD-L1 Proximity Assay as a Theranostic Marker for PD-1 Blockade in Patients with Metastatic Melanoma

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2022

von Girault, I. | Adam, J. | Shen, S. | +12

10

Circulating tumor DNA (ctDNA) serial analysis during progression on PD-1 blockade and later CTLA-4 rescue in patients with mismatch repair deficient metastatic colorectal cancer

enthalten in: Journal for immunotherapy of cancer | 2022

von Kasi, P. | Budde, G. | Krainock, M. | +6

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[72]